VTE Incidence After Rivaroxaban + Aspirin or SAPT After Lower-limb Revascularization
VTE Incidence After Rivaroxaban + Aspirin or SAPT After Lower-limb Revascularization
Recruiting · NCT06873321 · Registry updated 2025-03-12Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| VTE Incidence After Rivaroxaban + Aspirin or SAPT After Lower-limb Revascularization | Arterial Occlusive Diseases, Chronic Disease, Chronic Limb-Threatening Ischemia, Disease Attributes, Embolism and Thrombosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Thromboembolism, Venous Thrombosis, arteriosclerosis disorder, atherosclerosis, brain disorder, cardiovascular disorder, carotid artery disorder, carotid stenosis, central nervous system disorder, cerebrovascular disorder, ischemic disease, nervous system disorder, peripheral arterial disease, peripheral vascular disease, thrombotic disease, vascular disorder, venous thromboembolism | Recruiting | Phase 4 | 2025-03-12 | NCT06873321 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Science Valley Research Institute | 5 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Hospital das Clínicas, Federal University of Pernambuco | Pernambuco | Brazil | 1 |